Last Updated on June 22, 2023

Clinical Genitourinary Cancer- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Elsevier

Abbreviation: Clin. Genitourin. Cancer




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

3.09

SJR

 1.031

h-Index

 54

Rank

 4020

Important Details

Title Clinical Genitourinary Cancer
Standard Abbreviation Clin. Genitourin. Cancer
Type of Publication Journal
Discipline Urology (Q1); Oncology (Q2)
Impact Score 3.09
SCImago Journal Rank (SJR) 1.031
h-index 54
Overall Rank 4020
Publisher Name Elsevier
Publication Country United States
International Standard Serial Number (ISSN) 15587673
Coverage and History 2005-2022
Best Quartile Q1
Total Citations Received
(Last 3 Year)
1491

About Clinical Genitourinary Cancer


Clinical Genitourinary Cancer is a journal published by Elsevier. This journal covers the area[s] related to Urology, Oncology, etc. The coverage history of this journal is as follows: 2005-2022. The rank of this journal is 4020. This journal's impact score, h-index, and SJR are 3.09, 54, and 1.031, respectively. The ISSN of this journal is/are as follows: 15587673.

The best quartile of Clinical Genitourinary Cancer is Q1. This journal has received a total of 1491 citations during the last three years (Preceding 2022).


Clinical Genitourinary Cancer Impact Score 2022-2023


The latest impact score (IS) of the Clinical Genitourinary Cancer is 3.09. It is computed in the year 2023 as per its definition and based on Scopus data. 3.09

It is increased by a factor of around 0.15, and the percentage change is 5.1% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Clinical Genitourinary Cancer Impact Score 2023


Impact Score 2022 of Clinical Genitourinary Cancer is 3.09. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Clinical Genitourinary Cancer. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 3.09
2021 2.94
2020 2.50
2019 2.45
2018 2.14
2017 2.21
2016 2.45
2015 2.61
2014 2.58

Clinical Genitourinary Cancer h-index


  Table Setting

The h-index of Clinical Genitourinary Cancer is 54. By definition of the h-index, this journal has at least 54 published articles with more than 54 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Clinical Genitourinary Cancer ISSN


The International Standard Serial Number (ISSN) of Clinical Genitourinary Cancer is/are as follows: 15587673.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Clinical Genitourinary Cancer Ranking and SCImago Journal Rank (SJR)


The Clinical Genitourinary Cancer is ranked 4020 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 1.031.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Clinical Genitourinary Cancer Publisher


Table Setting

The publisher of Clinical Genitourinary Cancer is Elsevier. The publishing house of this journal is located in the United States. Its coverage history is as follows: 2005-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Clinical Genitourinary Cancer is Clin. Genitourin. Cancer. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Clin. Genitourin. Cancer') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Clinical Genitourinary Cancer


If your area of research or discipline is related to Urology, Oncology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Clinical Genitourinary Cancer?

The latest impact score of Clinical Genitourinary Cancer is 3.09. It is computed in the year 2023.


What is the h-index of Clinical Genitourinary Cancer?

The latest h-index of Clinical Genitourinary Cancer is 54. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Clinical Genitourinary Cancer?

The latest SCImago Journal Rank (SJR) of Clinical Genitourinary Cancer is 1.031. It is calculated in the year 2023.


What is the ranking of Clinical Genitourinary Cancer?

The latest ranking of Clinical Genitourinary Cancer is 4020. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Clinical Genitourinary Cancer?

Clinical Genitourinary Cancer is published by Elsevier. The publication country of this journal is United States.


What is the abbreviation of Clinical Genitourinary Cancer?

This standard abbreviation of Clinical Genitourinary Cancer is Clin. Genitourin. Cancer.


Is "Clinical Genitourinary Cancer" a Journal, Conference or Book Series?

Clinical Genitourinary Cancer is a journal published by Elsevier.


What is the scope of Clinical Genitourinary Cancer?

The scope of Clinical Genitourinary Cancer is as follows:

  • Urology
  • Oncology

For detailed scope of Clinical Genitourinary Cancer, check the official website of this journal.


What is the ISSN of Clinical Genitourinary Cancer?

The International Standard Serial Number (ISSN) of Clinical Genitourinary Cancer is/are as follows: 15587673.


What is the best quartile for Clinical Genitourinary Cancer?

The best quartile for Clinical Genitourinary Cancer is Q1.


What is the coverage history of Clinical Genitourinary Cancer?

The coverage history of Clinical Genitourinary Cancer is as follows 2005-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
European Union Politics Journal SAGE Publications Ltd 2250 72 2.64
Proceedings of the International Symposium on Power Semiconductor Devices and ICs Conference And Proceedings 7015 49 2.14
Tekstilec Trade Journal Faculty of Natural Sciences and Engineering, Tekstilec 19217 14 0.73
Cardiovascular Journal of Africa Journal Clinics Cardive Publishing (PTY)Ltd 16569 39 0.66
Geo-Info Journal Nederlandse Vereniging voor Kartografie 30490 2 0.00
WSEAS Transactions on Environment and Development Journal World Scientific and Engineering Academy and Society 17731 23 1.33
International Journal of Organizational Analysis Journal Emerald Group Publishing Ltd. 8713 36 3.53
Nan fang yi ke da xue xue bao = Journal of Southern Medical University Journal Nanfang Yi Ke Da Xue Xue Bao Bian ji Bu 18302 23 0.89
Biomarker Insights Journal Libertas Academica Ltd. 5159 38 3.46
Psicologia Clinica Journal Pontificia Universidade Catolica do Rio de Janeiro 23610 9 0.10

Check complete list




Clinical Genitourinary Cancer Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 3.09
2021 2.94
2020 2.50
2019 2.45
2018 2.14
2017 2.21
2016 2.45
2015 2.61
2014 2.58



Top Journals/Conferences in Urology

Lancet Neurology, The
Elsevier Ltd. | United Kingdom

European Urology
Elsevier | Netherlands

JAMA Neurology
American Medical Association | United States

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

Molecular Neurodegeneration
BioMed Central Ltd. | United Kingdom

Acta Neuropathologica
Springer Verlag | Germany

Neuro-Oncology
Oxford University Press | United Kingdom

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Alzheimer's and Dementia
John Wiley & Sons Inc. | United States

Journal of Neurology, Neurosurgery and Psychiatry
BMJ Publishing Group | United Kingdom

Autism in Adulthood
Mary Ann Liebert Inc. | United States

Sleep Medicine Reviews
Elsevier BV | United Kingdom

Ageing Research Reviews
Elsevier Ireland Ltd | Ireland

Stroke
American Heart Association | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All